박사

Midazolam Prevents Vascular Leakage by Inhibiting VEGF-induced ROS Generation and TGase2 Activation in Diabetic Retina

김민수 2017년
논문상세정보
    • 저자 김민수
    • 형태사항 26 cm: 49
    • 일반주기 지도교수: 하권수
    • 학위논문사항 강원대학교 일반대학원, Thesis(doctoral)-, 의학과, 2017. 2
    • KDC 510
    • 발행지 춘천
    • 언어 eng
    • 출판년 2017
    • 발행사항 강원대학교 일반대학원
    유사주제 논문( 7,588)
' Midazolam Prevents Vascular Leakage by Inhibiting VEGF-induced ROS Generation and TGase2 Activation in Diabetic Retina' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,576 0

0.0%

' Midazolam Prevents Vascular Leakage by Inhibiting VEGF-induced ROS Generation and TGase2 Activation in Diabetic Retina' 의 참고문헌

  • Yoo JO, Lim YC, Kim YM, Ha KS. Differential cytotoxic responses to low- and high-dose photodynamic therapy in human gastric and bladder cancer cells. Journal of cellular biochemistry. 2011,112(10):3061-71.
  • Yamauchi M, Omote K, Ninomiya T. Direct evidence for the role of nitric oxide on the glutamate-induced neuronal death in cultured cortical neurons. Brain research. 1998,780(2):253-9.
  • Wilson JX, Gelb AW. Free radicals, antioxidants, and neurologic injury: possible relationship to cerebral protection by anesthetics. Journal of neurosurgical anesthesiology. 2002,14(1):66-79.
  • White IW, Gelb AW, Wexler HR, Stiller CR, Keown PA. The effects of intravenous anaesthetic agents on human neutrophil chemiluminescence. Canadian Anaesthetists' Society journal. 1983,30(5):506-11.
  • Weydert CJ, Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nature protocols. 2010,5(1):51-66.
  • Torri G. Inhalation anesthetics: a review. Minerva anestesiologica. 2010,76(3):215- 28.
  • Stratford N, Murphy P. Effect of lipid and propofol on oxidation of haemoglobin by reactive oxygen species. British journal of anaesthesia. 1997,78(3):320-2.
  • Shibuta S, Kosaka J, Mashimo T, Fukuda Y, Yoshiya I. Nitric oxide-induced cytotoxicity attenuation by thiopentone sodium but not pentobarbitone sodium in primary brain cultures. British journal of pharmacology. 1998,124(4):804-10.
  • Sane DC, Kontos JL, Greenberg CS. Roles of transglutaminases in cardiac and vascular diseases. Frontiers in bioscience : a journal and virtual library. 2007,12:2530-45.
  • Ruan Q, Johnson GV. Transglutaminase 2 in neurodegenerative disorders. Frontiers in bioscience : a journal and virtual library. 2007,12:891-904.
  • Robert Loveridge FS. Anaesthetic preconditioning. Contin Educ Anaesth Crit Care Pain 2010, 10(2):38-42.
  • Rigoulet M, Devin A, Averet N, Vandais B, Guerin B. Mechanisms of inhibition and uncoupling of respiration in isolated rat liver mitochondria by the general anesthetic 2,6- diisopropylphenol. European journal of biochemistry. 1996,241(1):280-5.
  • Ratnakumari L, Hemmings HC, Jr. Effects of propofol on sodium channel-dependent sodium influx and glutamate release in rat cerebrocortical synaptosomes. Anesthesiology. 1997,86(2):428-39.
  • Rampil IJ, Mason P, Singh H. Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology. 1993,78(4):707-12.
  • Perouansky M. The quest for a unified model of anesthetic action: a century in Claude Bernard's shadow. Anesthesiology. 2012,117(3):465-74.
  • Park D, Choi SS, Ha KS. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments. Amino acids. 2010,39(3):619-31.
  • O'Malley C, Cunningham AJ. Physiologic changes during laparoscopy. Anesthesiology clinics of North America. 2001,19(1):1-19.
  • Nishina K, Akamatsu H, Mikawa K, Shiga M, Maekawa N, Obara H, et al. The inhibitory effects of thiopental, midazolam, and ketamine on human neutrophil functions. Anesthesia and analgesia. 1998,86(1):159-65.
  • Nemoto EM, Klementavicius R, Melick JA, Yonas H. Suppression of cerebral metabolic rate for oxygen (CMRO2) by mild hypothermia compared with thiopental. Journal of neurosurgical anesthesiology. 1996,8(1):52-9.
  • Nadalutti C, Viiri KM, Kaukinen K, Maki M, Lindfors K. Extracellular transglutaminase 2 has a role in cell adhesion, whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis. Cell proliferation. 2011,44(1):49-58.
  • Murphy PG, Ogilvy AJ, Whiteley SM. The effect of propofol on the neutrophil respiratory burst. European journal of anaesthesiology. 1996,13(5):471-3.
  • Murphy PG, Davies MJ, Columb MO, Stratford N. Effect of propofol and thiopentone on free radical mediated oxidative stress of the erythrocyte. British journal of anaesthesia. 1996,76(4):536-43.
  • Miyazaki H, Nakamura Y, Arai T, Kataoka K. Increase of glutamate uptake in astrocytes: a possible mechanism of action of volatile anesthetics. Anesthesiology. 1997,86(6):1359-66, discussion 8A.
  • Miao N, Nagao K, Lynch C, 3rd. Thiopental and methohexital depress Ca2+ entry into and glutamate release from cultured neurons. Anesthesiology. 1998,88(6):1643-53.
  • Maclver MB, Mikulec AA, Amagasu SM, Monroe FA. Volatile anesthetics depress glutamate transmission via presynaptic actions. Anesthesiology. 1996,85(4):823-34.
  • Macdonald RL, Olsen RW. GABAA receptor channels. Annual review of neuroscience. 1994,17:569-602.
  • Lima LM, Perazzo FF, Tavares Carvalho JC, Bastos JK. Anti-inflammatory and analgesic activities of the ethanolic extracts from Zanthoxylum riedelianum (Rutaceae) leaves and stem bark. The Journal of pharmacy and pharmacology. 2007,59(8):1151-8.
  • Lim YC, Bhatt MP, Kwon MH, Park D, Na S, Kim YM, et al. Proinsulin C-peptide prevents impaired wound healing by activating angiogenesis in diabetes. The Journal of investigative dermatology. 2015,135(1):269-78.
  • Lim YC, Bhatt MP, Kwon MH, Park D, Lee S, Choe J, et al. Prevention of VEGFmediated microvascular permeability by C-peptide in diabetic mice. Cardiovascular research. 2014,101(1):155-64.
  • Lee YJ, Jung SH, Kim SH, Kim MS, Lee S, Hwang J, et al. Essential Role of Transglutaminase 2 in Vascular Endothelial Growth Factor-Induced Vascular Leakage in the Retina of Diabetic Mice. Diabetes. 2016,65(8):2414-28.
  • Leduc LJ, Mitchell A. Intestinal ischemia after laparoscopic cholecystectomy. JSLS : Journal of the Society of Laparoendoscopic Surgeons. 2006,10(2):236-8.
  • Kwon MH, Jung SH, Kim YM, Ha KS. Simultaneous activity assay of two transglutaminase isozymes, blood coagulation factor XIII and transglutaminase 2, by use of fibrinogen arrays. Analytical chemistry. 2011,83(22):8718-24.
  • Kokita N, Hara A, Abiko Y, Arakawa J, Hashizume H, Namiki A. Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesthesia and analgesia. 1998,86(2):252-8.
  • Kim SY. Transglutaminase 2 in inflammation. Frontiers in bioscience : a journal and virtual library. 2006,11:3026-35.
  • Khan KS, Hayes, I., Buggy, D.J. Pharmacology of anaesthetic agents I: Intravenous anaesthetic agents. Continuing Education in Anaesthesia, Critical Care and Pain. 2014,14(3):100-5.
  • Kahraman S, Kilinc K, Dal D, Erdem K. Propofol attenuates formation of lipid peroxides in tourniquet-induced ischaemia-reperfusion injury. British journal of anaesthesia. 1997,78(3):279-81.
  • John Butterworth DCM, John Wasnick. Morgan and Mikhail's Clinical Anesthesiology, 5th edition2013. 199-222 p.
  • Irifune M, Takarada T, Shimizu Y, Endo C, Katayama S, Dohi T, et al. Propofolinduced anesthesia in mice is mediated by gamma-aminobutyric acid-A and excitatory amino acid receptors. Anesthesia and analgesia. 2003,97(2):424-9, table of contents.
  • Huang L, Haylor JL, Hau Z, Jones RA, Vickers ME, Wagner B, et al. Transglutaminase inhibition ameliorates experimental diabetic nephropathy. Kidney international. 2009,76(4):383-94.
  • Hammes HP. Pericytes and the pathogenesis of diabetic retinopathy. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2005,37 Suppl 1:39-43.
  • Godin DV, Mitchell MJ, Saunders BA. Studies on the interaction of barbiturates with reactive oxygen radicals: implications regarding barbiturate protection against cerebral ischaemia. Canadian Anaesthetists' Society journal. 1982,29(3):203-11.
  • Glantz L, Ginosar Y, Chevion M, Gozal Y, Elami A, Navot N, et al. Halothane prevents postischemic production of hydroxyl radicals in the canine heart. Anesthesiology. 1997,86(2):440-7.
  • Giulivi C, Cadenas E. The reaction of ascorbic acid with different heme iron redox states of myoglobin. Antioxidant and prooxidant aspects. FEBS letters. 1993,332(3):287-90.
  • Frohlich D, Rothe G, Schwall B, Schmid P, Schmitz G, Taeger K, et al. Effects of volatile anaesthetics on human neutrophil oxidative response to the bacterial peptide FMLP. British journal of anaesthesia. 1997,78(6):718-23.
  • Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature. 1994,367(6464):607-14.
  • Franks NP, Lieb WR. Do general anaesthetics act by competitive binding to specific receptors? Nature. 1984,310(5978):599-601.
  • Frank RN. Diabetic retinopathy. The New England journal of medicine. 2004,350(1):48-58.
  • Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. Retinopathy in diabetes. Diabetes care. 2004,27 Suppl 1:S84-7.
  • Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000,408(6809):239-47.
  • Farooq K, Hunter JM. Neuromuscular blocking agents and reversal agents. Anaesthesia & Intensive Care Medicine.12(6):266-70.
  • Di Sabatino A, Vanoli A, Giuffrida P, Luinetti O, Solcia E, Corazza GR. The function of tissue transglutaminase in celiac disease. Autoimmunity reviews. 2012,11(10):746-53.
  • Courtwright DT. Forces of habit drugs and the making of the modern world (1 ed.). Cambridge: Mass.: Harvard University Press., 2009. pp. 36–7 p.
  • Cossart R, Bernard C, Ben-Ari Y. Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies. Trends in neurosciences. 2005,28(2):108-15.
  • Chong WS, Hyun CL, Park MK, Park JM, Song HO, Park T, et al. Midazolam protects B35 neuroblastoma cells through Akt-phosphorylation in reactive oxygen species derived cellular injury. Korean journal of anesthesiology. 2012,62(2):166-71.
  • Cheng MA, Theard MA, Tempelhoff R. Intravenous agents and intraoperative neuroprotection. Beyond barbiturates. Critical care clinics. 1997,13(1):185-99.
  • Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, et al. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes/metabolism research and reviews. 2003,19(6):442-55.
  • Brownstein MJ. A brief history of opiates, opioid peptides, and opioid receptors. Proceedings of the National Academy of Sciences of the United States of America. 1993,90(12):5391-3.
  • Bowman WC. Neuromuscular block. British journal of pharmacology. 2006,147 Suppl 1:S277-86.
  • Boom M, Niesters M, Sarton E, Aarts L, Smith TW, Dahan A. Non-analgesic effects of opioids: opioid-induced respiratory depression. Current pharmaceutical design. 2012,18(37):5994-6004.
  • Bolinger MT, Antonetti DA. Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy. International journal of molecular sciences. 2016,17(9).
  • Biondich AS, Joslin JD. Coca: The History and Medical Significance of an Ancient Andean Tradition. Emergency medicine international. 2016,2016:4048764.
  • Bickler PE, Buck LT, Feiner JR. Volatile and intravenous anesthetics decrease glutamate release from cortical brain slices during anoxia. Anesthesiology. 1995,83(6):1233- 40.
  • Bhatt MP, Lim YC, Kim YM, Ha KS. C-peptide activates AMPKalpha and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes. Diabetes. 2013,62(11):3851-62.
  • Bhatt MP, Lim YC, Hwang J, Na S, Kim YM, Ha KS. C-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen speciesmediated transglutaminase 2 activation. Diabetes. 2013,62(1):243-53.
  • Bhatt MP, Lim YC, Ha KS. C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy. Cardiovascular research. 2014,104(2):234-44.
  • Basso M, Ratan RR. Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2013,33(6):809-18.
  • Barth J, Petermann W, Entzian P, Wustrow C, Wustrow J, Ohnhaus EE. Modulation of oxygen-free radicals from human leukocytes during halothane- and enflurane- induced general anesthesia. Acta anaesthesiologica Scandinavica. 1987,31(8):740-3.
  • Antonyak MA, Li B, Regan AD, Feng Q, Dusaban SS, Cerione RA. Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion. The Journal of biological chemistry. 2009,284(27):17914-25.
  • Ansley DM, Lee J, Godin DV, Garnett ME, Qayumi AK. Propofol enhances red cell antioxidant capacity in swine and humans. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 1998,45(3):233-9.
  • Alkire MT, Haier RJ, Barker SJ, Shah NK, Wu JC, Kao YJ. Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography. Anesthesiology. 1995,82(2):393-403, discussion 27A.
  • Alam MN, Bristi NJ, Rafiquzzaman M. Review on in vivo and in vitro methods evaluation of antioxidant activity. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society. 2013,21(2):143-52.